Portfolio

Preclinical company developing therapeutics targeting key biological pathways in fibrosis.

Preclinical company developing platform to correct RNA expression in neurology, oncology and rare diseases.

Preclinical company developing gene-editing platform for oncology and rare diseases.

Preclinical company developing immunotherapy platform for oncology applications.

Preclinical company developing therapies for neurodegenerative diseases.

Clinical stage company developing therapeutics for rare dermatological disorders.

Commercial company developing gene therapies for rare immunology disorders.

Clinical company developing therapeutics for rare brain tumors.

Clinical company developing platform of neuromodulators for neurology indications.